ImmunityBio, Inc. IBRX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s operating lease ROU assets?
- ImmunityBio, Inc. (IBRX) reported operating lease ROU assets of 11.1% in Q1 2026.
- How has ImmunityBio, Inc.'s operating lease ROU assets changed year-over-year?
- ImmunityBio, Inc.'s operating lease ROU assets increased by 0.9% year-over-year, from 11% to 11.1%.
- What is the long-term trend for ImmunityBio, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s operating lease ROU assets has grown at a -97.7% compound annual growth rate (CAGR), from 1,813,800,000% to 11.1%.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.